CD34 has a synergistic effect with vascular endothelial growth factor (VEGF), which together promote the angiogenesis and cell proliferation of HCC, and then lead to the metastasis of liver cancer and the formation of tumour thrombi, thus affecting the prognosis. The gene discussed is VEGFA; the disease is liver cancer.